Xiaoguang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Xiaoguang Li has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
Hua Qian
Daqing Oilfield General Hospital
12 shared publications- Takashi Hashimoto
Department of Dermatology Graduate School of Medicine, Osaka Metropolitan University Osaka Japan
11 shared publications Yangmin Gao
Dermatology Hospital of Jiangxi Province, Jiangxi Provincial Clinical Research Center for Skin Diseases, Candidate Branch of National Clinical Research Center for Skin Diseases, Nanchang, China
6 shared publicationsHuicheng Li
Dermatology Hospital of Jiangxi Province, Jiangxi Provincial Clinical Research Center for Skin Diseases, Candidate Branch of National Clinical Research Center for Skin Diseases, Dermatology Institute of Jiangxi Province, The Affiliated Dermatology Hospital of Nanchang University, Nanchang, China
4 shared publicationsLuhuai Shi
Dermatology Hospital of Jiangxi Province, Jiangxi Provincial Clinical Research Center for Skin Diseases, Candidate Branch of National Clinical Research Center for Skin Diseases, Dermatology Institute of Jiangxi Province, The Affiliated Dermatology Hospital of Nanchang University, Nanchang, China
4 shared publicationsWeijun Liu
Dermatology Hospital of Jiangxi Province, Jiangxi Provincial Clinical Research Center for Skin Diseases, Candidate Branch of National Clinical Research Center for Skin Diseases, Dermatology Institute of Jiangxi Province, The Affiliated Dermatology Hospital of Nanchang University, Nanchang, China
4 shared publications
Latest Publications
- 3 August 2026
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 22 (8) , 915-928
Direct immunofluorescence in the clinic for pemphigus and pemphigoid diseases
1. Autoimmune bullous diseases (AIBDs) are characterized by autoantibodies targeting structural proteins of the skin and mucous membranes, leading to blistering and erosions. The diagnosis of AIBDs...
- 3 August 2026
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 22 (8) , 915-928
Direct immunofluorescence in the clinic for pemphigus and pemphigoid diseases
1. Autoimmune bullous diseases (AIBDs) are characterized by autoantibodies targeting structural proteins of the skin and mucous membranes, leading to blistering and erosions. The diagnosis of AIBDs...
- 7 June 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8)
A Rare Case of Anti‐Integrin β4 IgG ‐Positive Bullous Pemphigoid Lacking Mucosal Lesions
- 7 June 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8)
A Rare Case of Anti‐Integrin β4 IgG ‐Positive Bullous Pemphigoid Lacking Mucosal Lesions
- Open Access
- 27 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1163-1165
Comparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study
This multicentre study compares four immunoassays for detecting antilaminin 332 IgG in mucous membrane pemphigoid. The keratinocyte footprint assay showed the highest diagnostic accuracy, while the laminin 332 Biochip® provided excellent specificity as a standardized and widely accessible diagnostic option.
- 27 February 2026
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (6) , 1163-1165
Open AccessComparative performance of four immunoassays for antilaminin 332 serum IgG in mucous membrane pemphigoid: a multicentre prospective blinded study
This multicentre study compares four immunoassays for detecting antilaminin 332 IgG in mucous membrane pemphigoid. The keratinocyte footprint assay showed the highest diagnostic accuracy, while the laminin 332 Biochip® provided excellent specificity as a standardized and widely accessible diagnostic option.
- Open Access
- 22 January 2025
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 380-383
The first case of paraneoplastic pemphigus positive for IgG autoantibodies against integrin α6
- 22 January 2025
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 380-383
Open AccessThe first case of paraneoplastic pemphigus positive for IgG autoantibodies against integrin α6
- Open Access
- 17 December 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 243-252
Dupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid
- 17 December 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 243-252
Open AccessDupilumab, corticosteroids and their combination for the treatment of bullous pemphigoid
- 6 December 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (4)
Atypical necrobiosis lipoidica of the face and scalp successfully treated with combined baricitinib and crisaborole
- 6 December 2024
- Published by Wiley in The Journal of Dermatology
- Vol. 52 (4)
Atypical necrobiosis lipoidica of the face and scalp successfully treated with combined baricitinib and crisaborole
- Open Access
- 14 November 2024
- Published by MDPI AG in Antibodies
- Vol. 13 (4) , 91
Ocular Mucous Membrane Pemphigoid Demonstrates a Distinct Autoantibody Profile from Those of Other Autoimmune Blistering Diseases: A Preliminary Study
Background: Ocular predominant mucous membrane pemphigoid (oMMP) is a severe subtype of autoimmune blistering disease (AIBD), which can result in scarring and vision loss. The diagnosis of oMMP is challenging as patients often have undetectable levels of circulating autoantibodies by conventional assays. Likewise, the principal autoantigen in oMMP has been an area of debate. Methods: In this preliminary experiment, we performed Phage Immunoprecipitation Sequencing (PhIP-seq) on sera from patients with oMMP, as well as non-ocular MMP, bullous pemphigoid, and mucocutaneous-type pemphigus vulgaris. Results: We identified several autoantigens unique to oMMP relative to other AIBDs. We then cross-referenced these antigens against previously published single-nuclei datasets, as well as the International Mouse Phenotyping Consortium Database. Several protein hits identified in our study demonstrated enriched expression on the anterior surface epithelia, including TNKS1BP1, SEC16B, FNBP4, CASZ1, GOLGB1, DOT1L, PRDM 15, LARP4B, and RPL6. Likewise, a previous study of mouse knockout models of murine analogs CASZ1, HIP1, and ELOA2 reported that these mice showed abnormalities in terms of the ocular surface and development in the eyes. Notably, PhIP-seq failed to identify the canonical markers of AIBDs such as BP180, BP230, desmogleins 1 and 3, or integrin β4, indicating that the patient autoantibodies react with conformational epitopes rather than linear epitopes. Conclusions: oMMP patients demonstrate a unique autoantibody repertoire relative to the other AIBDs. Further validation of the identified autoantibodies will shed light on their potentially pathogenic role.
- 14 November 2024
- Published by MDPI AG in Antibodies
- Vol. 13 (4) , 91
Open AccessOcular Mucous Membrane Pemphigoid Demonstrates a Distinct Autoantibody Profile from Those of Other Autoimmune Blistering Diseases: A Preliminary Study
Background: Ocular predominant mucous membrane pemphigoid (oMMP) is a severe subtype of autoimmune blistering disease (AIBD), which can result in scarring and vision loss. The diagnosis of oMMP is challenging as patients often have undetectable levels of circulating autoantibodies by conventional assays. Likewise, the principal autoantigen in oMMP has been an area of debate. Methods: In this preliminary experiment, we performed Phage Immunoprecipitation Sequencing (PhIP-seq) on sera from patients with oMMP, as well as non-ocular MMP, bullous pemphigoid, and mucocutaneous-type pemphigus vulgaris. Results: We identified several autoantigens unique to oMMP relative to other AIBDs. We then cross-referenced these antigens against previously published single-nuclei datasets, as well as the International Mouse Phenotyping Consortium Database. Several protein hits identified in our study demonstrated enriched expression on the anterior surface epithelia, including TNKS1BP1, SEC16B, FNBP4, CASZ1, GOLGB1, DOT1L, PRDM 15, LARP4B, and RPL6. Likewise, a previous study of mouse knockout models of murine analogs CASZ1, HIP1, and ELOA2 reported that these mice showed abnormalities in terms of the ocular surface and development in the eyes. Notably, PhIP-seq failed to identify the canonical markers of AIBDs such as BP180, BP230, desmogleins 1 and 3, or integrin β4, indicating that the patient autoantibodies react with conformational epitopes rather than linear epitopes. Conclusions: oMMP patients demonstrate a unique autoantibody repertoire relative to the other AIBDs. Further validation of the identified autoantibodies will shed light on their potentially pathogenic role.
- Open Access
- 16 April 2024
- Published by Springer Nature in Mycopathologia
- Vol. 189 (3) , 1-7
Clinical Characteristics and Pathogen Spectrum of Male Genital Fungal Infections in Nanchang Area, South China
The cutaneous fungal infections in male genitalia are relatively rare, and often present with various atypical clinical symptoms. It was mainly reported in a small number of case reports, while data with large number of patients were rarely reported. In this study, we reported 79 male patients with cutaneous fungal infections on scrotum or penis. The fungal infections were confirmed by microscopic examination directly and fungus culture. Clinical characteristics and predisposing factors were also collected. Of these 79 patients, 72 has lesions on scrotum, 5 on penis and 2 on both scrotum and penis. Trichophyton (T.) rubrum is the most common pathogen, found in 50 (67.6%) patients, which presented diverse clinical manifestation such as majorly erythematous, dry diffused scaly lesions without a clear border, slightly powdery and scutular scalings. Candida (C.) albicans is the secondly common pathogen, found in 21 (28.4%) patients, which also presented diverse lesions such as erythematous with dry whitish scaly lesions and erythematous erosion. The predisposing factors mainly included concomitant fungal infections on sites other than genitalia, especially inguinal region (tinea cruris), application of corticosteroid and high moisture. In conclusion, cutaneous fungal infections in male genitalia could be caused by different fungi, showed atypical or mild clinical appearances in most cases and might be a fungus reservoir, emphasizing the necessity to timely perform the fungi examinations and corresponding therapy.
- 16 April 2024
- Published by Springer Nature in Mycopathologia
- Vol. 189 (3) , 1-7
Open AccessClinical Characteristics and Pathogen Spectrum of Male Genital Fungal Infections in Nanchang Area, South China
The cutaneous fungal infections in male genitalia are relatively rare, and often present with various atypical clinical symptoms. It was mainly reported in a small number of case reports, while data with large number of patients were rarely reported. In this study, we reported 79 male patients with cutaneous fungal infections on scrotum or penis. The fungal infections were confirmed by microscopic examination directly and fungus culture. Clinical characteristics and predisposing factors were also collected. Of these 79 patients, 72 has lesions on scrotum, 5 on penis and 2 on both scrotum and penis. Trichophyton (T.) rubrum is the most common pathogen, found in 50 (67.6%) patients, which presented diverse clinical manifestation such as majorly erythematous, dry diffused scaly lesions without a clear border, slightly powdery and scutular scalings. Candida (C.) albicans is the secondly common pathogen, found in 21 (28.4%) patients, which also presented diverse lesions such as erythematous with dry whitish scaly lesions and erythematous erosion. The predisposing factors mainly included concomitant fungal infections on sites other than genitalia, especially inguinal region (tinea cruris), application of corticosteroid and high moisture. In conclusion, cutaneous fungal infections in male genitalia could be caused by different fungi, showed atypical or mild clinical appearances in most cases and might be a fungus reservoir, emphasizing the necessity to timely perform the fungi examinations and corresponding therapy.
- 21 June 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (10) , E354-E356
Anti‐laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone
- 21 June 2023
- Published by Wiley in The Journal of Dermatology
- Vol. 50 (10) , E354-E356
Anti‐laminin γ1 (p200) pemphigoid successfully treated with tofacitinib combined with prednisone
- Open Access
- 30 May 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1201163
Case Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review
Linear IgA/IgG bullous dermatosis (LAGBD) is a rare autoimmune subepidermal bullous disorder characterized by linear deposition of concurrent IgA and IgG autoantibodies along the basement membrane zone (BMZ). The clinical features of LAGBD can be diverse, including tense blisters, erosions, erythema, crusting and mucosa involvement, while papules or nodules are generally absent. In this study, we present a unique case of LAGBD, which showed prurigo nodularis-like clinical appearance on physical examination, linear deposition of IgG and C3 along the basement membrane zone (BMZ) in direct immunofluorescence (DIF), IgA autoantibodies against the 97-kDa and 120-kDa of BP180 and IgG autoantibodies against the 97-kDa of BP180 by immunoblotting (IB), while BP180 NC16a domain, BP230, and laminin 332 were negative by enzyme-linked immunosorbent assay (ELISA). After administration of minocycline, the skin lesions improved. We performed a literature review of LAGBD cases with heterogeneous autoantibodies and found clinical presentations of most cases resemble bullous pemphigoid (BP) and linear IgA bullous disease (LABD), which is consistent with previous reported findings. We aim to increase our understanding of this disorder and to enhance the importance of applying immunoblot analyses and other serological detection tools in clinic for precise diagnosis as well as accurate treatment strategy of various autoimmune bullous dermatoses.
- 30 May 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1201163
Open AccessCase Report: Prurigo nodularis-like linear IgA/IgG bullous dermatosis: a case report and literature review
Linear IgA/IgG bullous dermatosis (LAGBD) is a rare autoimmune subepidermal bullous disorder characterized by linear deposition of concurrent IgA and IgG autoantibodies along the basement membrane zone (BMZ). The clinical features of LAGBD can be diverse, including tense blisters, erosions, erythema, crusting and mucosa involvement, while papules or nodules are generally absent. In this study, we present a unique case of LAGBD, which showed prurigo nodularis-like clinical appearance on physical examination, linear deposition of IgG and C3 along the basement membrane zone (BMZ) in direct immunofluorescence (DIF), IgA autoantibodies against the 97-kDa and 120-kDa of BP180 and IgG autoantibodies against the 97-kDa of BP180 by immunoblotting (IB), while BP180 NC16a domain, BP230, and laminin 332 were negative by enzyme-linked immunosorbent assay (ELISA). After administration of minocycline, the skin lesions improved. We performed a literature review of LAGBD cases with heterogeneous autoantibodies and found clinical presentations of most cases resemble bullous pemphigoid (BP) and linear IgA bullous disease (LABD), which is consistent with previous reported findings. We aim to increase our understanding of this disorder and to enhance the importance of applying immunoblot analyses and other serological detection tools in clinic for precise diagnosis as well as accurate treatment strategy of various autoimmune bullous dermatoses.